Literature DB >> 28295416

Validating Harmful Alcohol Use as a Phenotype for Genetic Discovery Using Phosphatidylethanol and a Polymorphism in ADH1B.

Amy C Justice1,2,3, Kathleen A McGinnis2, Janet P Tate1, Ke Xu1,2, William C Becker1,2, Hongyu Zhao1,3, Joel Gelernter1,2, Henry R Kranzler4.   

Abstract

BACKGROUND: Although alcohol risk is heritable, few genetic risk variants have been identified. Longitudinal electronic health record (EHR) data offer a largely untapped source of phenotypic information for genetic studies, but EHR-derived phenotypes for harmful alcohol exposure have yet to be validated. Using a variant of known effect, we used EHR data to develop and validate a phenotype for harmful alcohol exposure that can be used to identify unknown genetic variants in large samples. Herein, we consider the validity of 3 approaches using the 3-item Alcohol Use Disorders Identification Test consumption measure (AUDIT-C) as a phenotype for harmful alcohol exposure.
METHODS: First, using longitudinal AUDIT-C data from the Veterans Aging Cohort Biomarker Study Cohort (VACS-BC), we compared 3 metrics of AUDIT-C using correlation coefficients: (i) AUDIT-C closest to blood sampling (closest AUDIT-C), (ii) the highest value (highest AUDIT-C), (iii) and longitudinal trajectories generated using joint trajectory modeling (AUDIT-C trajectory). Second, we compared the associations of the 3 AUDIT-C metrics with phosphatidylethanol (PEth), a direct, quantitative biomarker for alcohol in the overall sample using chi-square tests for trend. Last, in the subsample of African Americans (AAs; n = 1,503), we compared the associations of the 3 AUDIT-C metrics with rs2066702 a common missense (Arg369Cys) polymorphism of the ADH1B gene, which encodes an alcohol dehydrogenase isozyme.
RESULTS: The sample (n = 1,851, 94.5% male, 65% HIV+, mean age 52 years) had a median of 7 AUDIT-C scores over a median of 6.1 years. Highest AUDIT-C and AUDIT-C trajectory were correlated r = 0.86. The closest AUDIT-C was obtained a median of 2.26 years after the VACS-BC blood draw. Overall and among AAs, all 3 AUDIT-C metrics were associated with PEth (all p < 0.05), but the gradient was steepest with AUDIT-C trajectory. Among AAs (36% with the protective ADH1B allele), the association of rs2066702 with AUDIT-C trajectory and highest AUDIT-C was statistically significant (p < 0.05), and the gradient was steeper for the AUDIT-C trajectory than for the highest AUDIT-C. The closest AUDIT-C was not statistically significantly associated with rs2066702.
CONCLUSIONS: EHR data can be used to identify complex phenotypes such as harmful alcohol use. The validity of the phenotype may be enhanced through the use of longitudinal trajectories.
Copyright © 2017 by the Research Society on Alcoholism.

Entities:  

Keywords:  zzm321990ADH1Bzzm321990; AUDIT-C; African American; Alcohol Use Disorder; Arg369Cys; Electronic Health Record Data; Trajectory Analyses; rs2066702

Mesh:

Substances:

Year:  2017        PMID: 28295416      PMCID: PMC5501250          DOI: 10.1111/acer.13373

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  14 in total

1.  Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases.

Authors:  Dawei Li; Hongyu Zhao; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2011-04-17       Impact factor: 13.382

2.  Comparing alcohol screening measures among HIV-infected and -uninfected men.

Authors:  Kathleen A McGinnis; Amy C Justice; Kevin L Kraemer; Richard Saitz; Kendall J Bryant; David A Fiellin
Journal:  Alcohol Clin Exp Res       Date:  2012-10-10       Impact factor: 3.455

3.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

Review 4.  Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses.

Authors:  Amy B Hart; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

5.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

6.  Prevalence and correlates of at-risk drinking among older adults: the project SHARE study.

Authors:  Andrew J Barnes; Alison A Moore; Haiyong Xu; Alfonso Ang; Louise Tallen; Michelle Mirkin; Susan L Ettner
Journal:  J Gen Intern Med       Date:  2010-04-16       Impact factor: 5.128

7.  Phosphatidylethanol Levels Are Elevated and Correlate Strongly with AUDIT Scores in Young Adult Binge Drinkers.

Authors:  Mariann R Piano; Stephanie Tiwari; Lauren Nevoral; Shane A Phillips
Journal:  Alcohol Alcohol       Date:  2015-06-07       Impact factor: 2.826

Review 8.  Ethanol metabolites: their role in the assessment of alcohol intake.

Authors:  Friedrich M Wurst; Natasha Thon; Michel Yegles; Alexandra Schrück; Ulrich W Preuss; Wolfgang Weinmann
Journal:  Alcohol Clin Exp Res       Date:  2015-09-07       Impact factor: 3.455

9.  ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry.

Authors:  L J Bierut; A M Goate; N Breslau; E O Johnson; S Bertelsen; L Fox; A Agrawal; K K Bucholz; R Grucza; V Hesselbrock; J Kramer; S Kuperman; J Nurnberger; B Porjesz; N L Saccone; M Schuckit; J Tischfield; J C Wang; T Foroud; J P Rice; H J Edenberg
Journal:  Mol Psychiatry       Date:  2011-10-04       Impact factor: 15.992

10.  Genetic research: who is at risk for alcoholism.

Authors:  Tatiana Foroud; Howard J Edenberg; John C Crabbe
Journal:  Alcohol Res Health       Date:  2010
View more
  10 in total

1.  Salivary microRNAs identified by small RNA sequencing and machine learning as potential biomarkers of alcohol dependence.

Authors:  Andrew J Rosato; Xiaochun Chen; Yoshiaki Tanaka; Lindsay A Farrer; Henry R Kranzler; Yaira Z Nunez; David C Henderson; Joel Gelernter; Huiping Zhang
Journal:  Epigenomics       Date:  2019-05-29       Impact factor: 4.778

2.  AUDIT-C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations.

Authors:  Amy C Justice; Rachel V Smith; Janet P Tate; Kathleen McGinnis; Ke Xu; William C Becker; Kuang-Yao Lee; Kevin Lynch; Ning Sun; John Concato; David A Fiellin; Hongyu Zhao; Joel Gelernter; Henry R Kranzler
Journal:  Addiction       Date:  2018-08-01       Impact factor: 6.526

3.  Differentiating Types of Self-Reported Alcohol Abstinence.

Authors:  Kirsha S Gordon; Kathleen McGinnis; Cecilia Dao; Christopher T Rentsch; Aeron Small; Rachel Vickers Smith; Rachel L Kember; Joel Gelernter; Henry R Kranzler; Kendall J Bryant; Janet P Tate; Amy C Justice
Journal:  AIDS Behav       Date:  2020-02

4.  Using DNA methylation to validate an electronic medical record phenotype for smoking.

Authors:  Kathleen A McGinnis; Amy C Justice; Janet P Tate; Henry R Kranzler; Hilary A Tindle; William C Becker; John Concato; Joel Gelernter; Boyang Li; Xinyu Zhang; Hongyu Zhao; Kristina Crothers; Ke Xu
Journal:  Addict Biol       Date:  2018-10-04       Impact factor: 4.280

5.  Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected.

Authors:  Oghenowede Eyawo; Kathleen A McGinnis; Amy C Justice; David A Fiellin; Judith A Hahn; Emily C Williams; Adam J Gordon; Brandon D L Marshall; Kevin L Kraemer; Stephen Crystal; Julie R Gaither; E Jennifer Edelman; Kendall J Bryant; Janet P Tate
Journal:  J Acquir Immune Defic Syndr       Date:  2018-02-01       Impact factor: 3.731

6.  Longitudinal Drinking Patterns and Their Clinical Correlates in Million Veteran Program Participants.

Authors:  Rachel Vickers Smith; Henry R Kranzler; Amy C Justice; Janet P Tate
Journal:  Alcohol Clin Exp Res       Date:  2019-02-03       Impact factor: 3.455

7.  Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations.

Authors:  Henry R Kranzler; Hang Zhou; Rachel L Kember; Rachel Vickers Smith; Amy C Justice; Scott Damrauer; Philip S Tsao; Derek Klarin; Aris Baras; Jeffrey Reid; John Overton; Daniel J Rader; Zhongshan Cheng; Janet P Tate; William C Becker; John Concato; Ke Xu; Renato Polimanti; Hongyu Zhao; Joel Gelernter
Journal:  Nat Commun       Date:  2019-04-02       Impact factor: 14.919

8.  Racial/ethnic differences in the association between alcohol use and mortality among men living with HIV.

Authors:  Kara M Bensley; Kathleen A McGinnis; David A Fiellin; Adam J Gordon; Kevin L Kraemer; Kendall J Bryant; E Jennifer Edelman; Stephen Crystal; Julie R Gaither; P Todd Korthuis; Brandon D L Marshall; India J Ornelas; K C Gary Chan; Julia C Dombrowski; John C Fortney; Amy C Justice; Emily C Williams
Journal:  Addict Sci Clin Pract       Date:  2018-01-22

9.  Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target.

Authors:  Falk W Lohoff; Toni-Kim Clarke; Zachary A Kaminsky; Rosie M Walker; Mairead L Bermingham; Jeesun Jung; Stewart W Morris; Daniel Rosoff; Archie Campbell; Miruna Barbu; Katrin Charlet; Mark Adams; Jisoo Lee; David M Howard; Emma M O'Connell; Heather Whalley; David J Porteous; Andrew M McIntosh; Kathryn L Evans
Journal:  Mol Psychiatry       Date:  2021-12-02       Impact factor: 13.437

10.  DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations.

Authors:  Xiaoyu Liang; Amy C Justice; Kaku So-Armah; John H Krystal; Rajita Sinha; Ke Xu
Journal:  Mol Psychiatry       Date:  2020-02-07       Impact factor: 13.437

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.